Aileron Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $134 | $0 |
Gross Profit | -4 | -59 | |
EBITDA | -9,035 | -7,146 | |
EBIT | -9,039 | -7,205 | |
Net Income | -8,942 | -7,113 | -7,339 |
Net Change In Cash | 0 | 134 | 0 |
Free Cash Flow | -8,389 | -5,271 | -10,391 |
Cash | 21,917 | 12,067 | 17,313 |
Basic Shares | 19,911 | 8,301 | 4,885 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -119 | -169 | -121 | -163 |
EBITDA | -15,613 | -27,478 | -26,484 | -20,333 |
EBIT | -15,732 | -27,647 | -26,605 | -20,496 |
Net Income | -15,732 | -27,011 | -25,764 | -21,818 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 1,735 | |||
Free Cash Flow | -19,808 | -24,865 | -23,911 | -20,481 |
Cash | 17,313 | 5,194 | 3,600 | 7,046 |
Basic Shares | 4,598 | 4,539 | 4,440 | 1,743 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.27 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.86 |
2023-12-31 | -$1.54 |
